Received May 26, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
12 year old boy passed out after receiving Menveo/Passes out; This serious case was reported by a physician via sales rep and described the occurrence of fainting in a 12-year-old male patient who received Men ACWY-CRM NVS (Menveo) solution for injection for prophylaxis. On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced fainting (Verbatim: 12 year old boy passed out after receiving Menveo/Passes out) (serious criteria GSK medically significant). The outcome of the fainting was resolved. The reporter considered the fainting to be related to Menveo. The company considered the fainting to be unrelated to Menveo. Additional Information: GSK Receipt Date: 21-MAY-2026 The batch number was not provided upon follow up with the reporter.; Sender's Comments: A case of Syncope, unknown time after receiving Menveo in a 12-year-old male patient. Case lacks further information on time to onset, medical history, concurrent conditions and laboratory data. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow-up has not been received.